Suchergebnisse - "Gassenmaier, Maximilian"

PubPharm (33)

1

Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy : A single-institutional cohort study

enthalten in: Journal of the American Academy of Dermatology | 2024

von Wagner, N. | Knierim, S. | Luttermann, F. | +11

2

Diagnostic and prognostic classification of atypical spitzoid tumours based on histology and genomic aberrations : A prospective cohort study with long-term follow-up

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Gassenmaier, M. | Soltanpour, N. | Held, L. | +7

3

Histological and Immunohistochemical Changes of Congenital Melanocytic Nevi With Age

enthalten in: The American Journal of dermatopathology | 2021

von Gassenmaier, M. | Häfner, H. | Hahn, M. | +3

4

Micrographic Surgery Allows Fascia Preservation in Dermatofibro-sarcoma Protuberans

enthalten in: Acta dermato-venereologica | 2021

von Gassenmaier, M. | Weber, E. | Leiter, U. | +6

5

Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas

enthalten in: Cancers | 2021

von Gassenmaier, M. | Hahn, M. | Metzler, G. | +6

6

Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies : a multicenter cohort study

enthalten in: Journal for immunotherapy of cancer | 2021

von Wagner, N. | Lenders, M. | Kühl, K. | +36

7

Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Knispel, S. | Gassenmaier, M. | Menzies, A. | +36

8

Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors

enthalten in: Cancer immunology, immunotherapy : CII | 2021

von Winter, J. | Lenders, M. | Gassenmaier, M. | +10

9

Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors

enthalten in: Targeted oncology | 2021

von Gassenmaier, M. | Lenders, M. | Forschner, A. | +5

10

Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors

enthalten in: Targeted oncology | 2021

von Gassenmaier, M. | Lenders, M. | Forschner, A. | +5